Next Article in Journal
Cooked Red Lentils Dose-Dependently Modulate the Colonic Microenvironment in Healthy C57Bl/6 Male Mice
Next Article in Special Issue
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery
Previous Article in Journal
Pre-Conception Maternal Food Intake and the Association with Childhood Allergies
Previous Article in Special Issue
Agrp-Specific Ablation of Scly Protects against Diet-Induced Obesity and Leptin Resistance
Open AccessArticle

Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death

Institut für Experimentelle Endokrinologie, Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, D-13353 Berlin, Germany
Department of Clinical Sciences, Malmö, Lund University, SE 214 28 Malmö, Sweden
Sphingotec GmbH, Neuendorfstrasse 15A, D-16761 Hennigsdorf, Germany
Department of Internal Medicine, Clinical Research Center, Skåne University Hospital, Jan Waldenströms gata 35, Bldg. 91, SE 214 28 Malmö, Sweden
Author to whom correspondence should be addressed.
Nutrients 2019, 11(8), 1852;
Received: 24 July 2019 / Revised: 5 August 2019 / Accepted: 7 August 2019 / Published: 9 August 2019
(This article belongs to the Special Issue The Role of Selenium in Health and Disease)
Selenoprotein-P (SELENOP) is the main carrier of selenium to target organs and reduces tissue oxidative stress both directly and by delivering selenium to protective selenoproteins. We tested if the plasma concentration of SELENOP predicts cardiovascular morbidity and mortality in the primary preventive setting. SELENOP was measured from the baseline exam in 2002–2006 of the Malmö Preventive Project, a population-based prospective cohort study, using a validated ELISA. Quintiles of SELENOP concentration were related to the risk of all-cause mortality, cardiovascular mortality, and a first cardiovascular event in 4366 subjects during a median (interquartile range) follow-up time of 9.3 (8.3–11) years using Cox proportional Hazards Model adjusting for cardiovascular risk factors. Compared to subjects in the lowest quintile of SELENOP, the risk of all three endpoints was significantly lower in quintiles 2–5. The risk (multivariate adjusted hazard ratio, 95% CI) decreased gradually with the lowest risk in quintile 4 for all-cause mortality (0.57, 0.48–0.69) (p < 0.001), cardiovascular mortality (0.52, 0.37–0.72) (p < 0.001), and first cardiovascular event (0.56, 0.44–0.71) (p < 0.001). The lower risk of a first cardiovascular event in quintiles 2–5 as compared to quintile 1 was significant for both coronary artery disease and stroke. We conclude that the 20% with lowest SELENOP concentrations in a North European population without history of cardiovascular disease have markedly increased risk of cardiovascular morbidity and mortality, and preventive selenium supplementation studies stratified for these subjects are warranted. View Full-Text
Keywords: Selenoprotein-P; selenium; cardiovascular disease; prevention; supplementation Selenoprotein-P; selenium; cardiovascular disease; prevention; supplementation
Show Figures

Figure 1

MDPI and ACS Style

Schomburg, L.; Orho-Melander, M.; Struck, J.; Bergmann, A.; Melander, O. Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death. Nutrients 2019, 11, 1852.

AMA Style

Schomburg L, Orho-Melander M, Struck J, Bergmann A, Melander O. Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death. Nutrients. 2019; 11(8):1852.

Chicago/Turabian Style

Schomburg, Lutz; Orho-Melander, Marju; Struck, Joachim; Bergmann, Andreas; Melander, Olle. 2019. "Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death" Nutrients 11, no. 8: 1852.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop